… eligible for Medicare doesn’t mean that you have to take it. In general, if you have other coverage through group health insurance, you can keep that coverage. Then, if you later lose that coverage, you can typically turn to Medicare for benefits. …
Category: Dialysis
Advocates Across U.S. to Bring “My Kidneys, My Life” Mantra to…
… the Centers for Disease Control and Prevention, National Institute of Diabetes and Digestive and Kidney Diseases, and Health Resources and Services Administration. At the Summit, individuals who have kidney disease, dialysis patients, living donors, …
Valentine’s Day Couple
… days would be when Ralph would not remember who Anna was and he would not sleep, she said. Anna also has had health problems. She suffered several strokes that affected her memory and has chronic back problems, the result of an accidental fall that …
Increasing kidney failures lead to upsurge in dialysis centers
… that can run between $1,500 and $2,000 weekly, said Dr. Sergio Infante, a nephrologist at Loma Linda University Health. End-stage kidney disease is the last stage the ailment, when the organs can no longer remove waste and excess water from the …
Longtime SCE Employee’s Daughter Needs a Kidney Transplant
… members have been tested to see if they are possible matches to donate. Her father and mother were not a match due to health issues and her sister also carries the Lupus gene. In April, the Ramos’ thought their prayers had finally been answered when …
New dialysis unit planned for Digby
… dialysis unit at Kentville’s Valley Regional Hospital. It will replace a smaller unit at the Western Kings Memorial Health Centre in Berwick and can provide treatment to higher-risk patients who often must travel to Halifax. “With a new dialysis …
Amgen updates agreement with DaVita for dialysis treatment
Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico.
We’re Bullish on Wide-Moat Amgen
Amgen has its roots in providing supportive-care products to kidney disease and cancer patients, and free cash flow as a percentage of sales hovers near 40% as the company undertakes massive cost-cutting and improves manufacturing. Strong newer blockbusters like Prolia/Xgeva and future blockbuster Repatha should defend Amgen’s wide economic moat from erosion caused by biosimilar and branded competition.
His struggle continues, his hope kindled
… from kidney failure can still lead positive lives. The support group meetings, which help members manage their health as effectively as possible, buoy his spirits despite ongoing setbacks, he said. During the December 2015 interview, the Meridian, …